Suppr超能文献

CRM1核输出蛋白在正常发育和疾病中的作用

The CRM1 nuclear export protein in normal development and disease.

作者信息

Nguyen Kevin T, Holloway Michael P, Altura Rachel A

机构信息

Department of Pediatrics, Division of Pediatric Hematology-Oncology, Hasbro Children's Hospital and The Warren Alpert Medical School at Brown University Providence, Rhode Island, USA.

出版信息

Int J Biochem Mol Biol. 2012;3(2):137-51. Epub 2012 May 18.

Abstract

CRM1 (Chromosomal Maintenance 1, also known as Exportin 1) is the major mammalian export protein that facilitates the transport of large macromolecules including RNA and protein across the nuclear membrane to the cytoplasm. The gene encoding CRM1 was originally identified in yeast as required to maintain higher order chromosome structure. In mammalian cells, CRM1 was found to bind several nuclear pore proteins hence its role in nuclear-cytosolic transport was discovered. In addition to nuclear-cytosolic transport, CRM1 also plays a role in centrosome duplication and spindle assembly, especially in response to DNA damage. The crystal structure of CRM1 suggests a complex protein that binds the Ran protein bound to GTP, allowing for a conformational change that facilitates binding to different cargo proteins through a nuclear export signal (NES). Included in the cadre of cargo are multiple tumor suppressor and oncoproteins as p53, BRCA1, Survivin, NPM, and APC, which function in the nucleus to regulate transcription or aid in chromosomal assembly and movement. An imbalance in the cytosolic level of these proteins has been observed in cancer cells, resulting in either inactivation (tumor suppressor) or an excess of anti-apoptotic activity (oncoprotein). Thus, the concept of inhibiting CRM1 has been explored as a potential therapeutic intervention. Indeed, inhibition of CRM1 by a variety of small molecules that interfere with cargo-NES binding results in cancer cell death. Whether all of these proteins together are responsible for this phenotype or whether specific proteins are required for this effect is unclear at this time.

摘要

CRM1(染色体维持蛋白1,也称为输出蛋白1)是主要的哺乳动物输出蛋白,它促进包括RNA和蛋白质在内的大分子穿过核膜运输到细胞质中。编码CRM1的基因最初在酵母中被鉴定为维持高阶染色体结构所必需的基因。在哺乳动物细胞中,发现CRM1与几种核孔蛋白结合,因此发现了它在核质运输中的作用。除核质运输外,CRM1在中心体复制和纺锤体组装中也发挥作用,尤其是在对DNA损伤的反应中。CRM1的晶体结构表明它是一种复杂的蛋白质,能结合与GTP结合的Ran蛋白,从而发生构象变化,便于通过核输出信号(NES)与不同的货物蛋白结合。货物蛋白包括多种肿瘤抑制蛋白和癌蛋白,如p53、BRCA1、生存素、核仁磷酸蛋白和腺瘤性息肉病蛋白,它们在细胞核中发挥作用以调节转录或协助染色体组装和移动。在癌细胞中观察到这些蛋白质的胞质水平失衡,导致肿瘤抑制蛋白失活或抗凋亡活性过强(癌蛋白)。因此,抑制CRM1的概念已被探索作为一种潜在的治疗干预措施。事实上,多种干扰货物蛋白与NES结合的小分子对CRM1的抑制会导致癌细胞死亡。目前尚不清楚所有这些蛋白质是否共同导致这种表型,或者这种效应是否需要特定的蛋白质。

相似文献

1
The CRM1 nuclear export protein in normal development and disease.
Int J Biochem Mol Biol. 2012;3(2):137-51. Epub 2012 May 18.
2
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Nat Cell Biol. 2005 Aug;7(8):823-30. doi: 10.1038/ncb1282. Epub 2005 Jul 24.
3
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.
Exp Cell Res. 1998 Aug 1;242(2):540-7. doi: 10.1006/excr.1998.4136.
4
Leptomycin B alters the subcellular distribution of CRM1 (Exportin 1).
Biochem Biophys Res Commun. 2017 Jun 24;488(2):253-258. doi: 10.1016/j.bbrc.2017.04.042. Epub 2017 Apr 12.
6
Mechanisms of Nuclear Export in Cancer and Resistance to Chemotherapy.
Cancers (Basel). 2016 Mar 14;8(3):35. doi: 10.3390/cancers8030035.
7
Mechanistic insights from the recent structures of the CRM1 nuclear export complex and its disassembly intermediate.
Biophysics (Nagoya-shi). 2012 Nov 30;8:145-50. doi: 10.2142/biophysics.8.145. eCollection 2012.
8
Crm1 is a mitotic effector of Ran-GTP in somatic cells.
Nat Cell Biol. 2005 Jun;7(6):626-32. doi: 10.1038/ncb1263.
9
An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1.
EMBO J. 2010 Jun 16;29(12):2002-13. doi: 10.1038/emboj.2010.89. Epub 2010 May 18.
10
Structural Basis of Targeting the Exportin CRM1 in Cancer.
Cells. 2015 Sep 21;4(3):538-68. doi: 10.3390/cells4030538.

引用本文的文献

2
Selinexor's Immunomodulatory Impact in Advancing Multiple Myeloma Treatment.
Cells. 2025 Mar 13;14(6):430. doi: 10.3390/cells14060430.
4
Itaconate and its derivatives as anti-pathogenic agents.
RSC Adv. 2025 Feb 10;15(6):4408-4420. doi: 10.1039/d4ra08298b. eCollection 2025 Feb 6.
6
Emerging Infectious Diseases and the Eye: Ophthalmic Manifestations, Pathogenesis, and One Health Perspectives.
Int Ophthalmol Clin. 2024 Oct 1;64(4):39-54. doi: 10.1097/IIO.0000000000000539. Epub 2024 Oct 29.
7
The Potential of Nuclear Pore Complexes in Cancer Therapy.
Molecules. 2024 Oct 12;29(20):4832. doi: 10.3390/molecules29204832.
8
Development of a UPLC-MS/MS method for quantifying KPT-335 (Verdinexor) in feline plasma for a study of PK.
Front Vet Sci. 2024 Jul 26;11:1438295. doi: 10.3389/fvets.2024.1438295. eCollection 2024.
10
C646 degrades Exportin-1 to modulate p300 chromatin occupancy and function.
Cell Chem Biol. 2024 Jul 18;31(7):1363-1372.e8. doi: 10.1016/j.chembiol.2024.05.016. Epub 2024 Jun 24.

本文引用的文献

1
Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer.
J Biol Chem. 2012 Mar 30;287(14):10885-93. doi: 10.1074/jbc.M111.308791. Epub 2012 Feb 9.
3
The nucleoporin-like protein NLP1 (hCG1) promotes CRM1-dependent nuclear protein export.
J Cell Sci. 2012 Jan 1;125(Pt 1):144-54. doi: 10.1242/jcs.090316. Epub 2012 Jan 16.
4
Nuclear export of proteins and drug resistance in cancer.
Biochem Pharmacol. 2012 Apr 15;83(8):1021-32. doi: 10.1016/j.bcp.2011.12.016. Epub 2011 Dec 20.
5
Deconstructing p53 transcriptional networks in tumor suppression.
Trends Cell Biol. 2012 Feb;22(2):97-106. doi: 10.1016/j.tcb.2011.10.006. Epub 2011 Dec 9.
6
Wnt signaling and colon tumorigenesis--a view from the periphery.
Exp Cell Res. 2011 Nov 15;317(19):2748-58. doi: 10.1016/j.yexcr.2011.08.010. Epub 2011 Aug 22.
8
p53: guardian of ploidy.
Mol Oncol. 2011 Aug;5(4):315-23. doi: 10.1016/j.molonc.2011.07.007. Epub 2011 Jul 30.
9
TP53 mutations in human cancer: database reassessment and prospects for the next decade.
Adv Cancer Res. 2011;110:107-39. doi: 10.1016/B978-0-12-386469-7.00005-0.
10
The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage.
Biochim Biophys Acta. 2011 Jul;1809(7):316-26. doi: 10.1016/j.bbagrm.2011.05.017. Epub 2011 Jun 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验